bpc 157 clinical trials human evidence bpc-157 review safety regulatory status Compounded BPC-157 in Johnson City bpc-157 human clinical trials evidence
Description
FAQs on Vitamin B12 vs
The primary treatment is immunomodulation (IVIG, plasma exchange, or immunosuppressants)
Health Canada does not authorize it for personal, medical, or veterinary use
A.DiegelmanP.et al (2007)
BPC-157 is so widely available that I doubt any pharmaceutical company would invest in the necessary research to prove or disprove its efficacy and safety, since they are unlikely to gain from it financially
